Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.

China's low birth rate and aging population are ending any hopes Beijing had of overtaking the U.S. as an economic giant.

GUANGZHOU, China ... in the central nervous system (CNS) and autoimmune fields. Leveraging its proprietary Drug Studio AI platform, Fermion prioritizes high target selectivity and tissue targeting ...

Anduril, a military drone start-up with links to Trump’s tech advisers, says U.S. military power needs rebuilding around ...

Cyber Insights 2025 examines expert opinions on the expected evolution of more than a dozen areas of cybersecurity interest over the next 12 months. We spoke to hundreds of individual experts to gain ...

The Global Equity composite fell 0.86% gross of fees in the fourth quarter, in line with the 0.89% decline of the MSCI ACWI ...

A man who taped a sinister note to a Chinese ex-official’s door in New Jersey was sentenced Wednesday to 16 months in prison.

JPMorgan’s Global CISO Pat Opet discusses overcoming cyber regulatory fragmentation and securing a broadening supply chain in ...

Read the Latest Union Budget 2024 News on The Economic Times. Discover Latest Budget Updates, India Budget Expectations, Budget Announcements, by Nirmala Sitharaman and more.

Confusion among strategists evidenced by outlook for interest rates; S-REITs staying lethargic; data centres in focus ...